Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-18

Clinical Trial Update: Impact in Older Adults of Reducing Anticholinergic and Sedative Rx Burden on Physical Function Measured by Wearables [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the impact of reducing anticholinergic and sedative medications on physical function in older adults, measured by wearables.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre de recherche du Centre hospitalier universitaire de Sherbrooke | Conditions: Deprescribing Anticholinergic and Sedative Medications, Physical Function | Phase 4 | Status: UNKNOWN